Trials / Terminated
TerminatedNCT02015637
Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea
A Comparative Evaluation of the Single-dose Efficacy of Oral Delafloxacin Versus the Single-dose Efficacy of an Intramuscular Injection of Ceftriaxone in Subjects With Uncomplicated Urogenital Gonorrhea
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 460 (actual)
- Sponsor
- Melinta Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of a single oral dose of delafloxacin versus a single intramuscular injection of ceftriaxone in subjects with uncomplicated cervical, urethral, rectal, or pharyngeal gonorrhea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Delafloxacin | single dose |
| DRUG | Ceftriaxone | single dose |
Timeline
- Start date
- 2014-01-23
- Primary completion
- 2014-11-01
- Completion
- 2014-12-10
- First posted
- 2013-12-19
- Last updated
- 2018-06-20
- Results posted
- 2018-04-26
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02015637. Inclusion in this directory is not an endorsement.